The U.S. Food and Drug Administration (FDA) made yet another questionable decision by issuing an emergency use authorization (EUA) for Roche’s IL-6 inhibitor called Actemra/RoActemra…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.